Health Net, a prominent Medi-Cal managed care health plan in California and part of Centene Corporation, announced today its recognition as one of “America’s Greatest Workplaces for LGBTQ+ 2024” by…
Researchers have made a groundbreaking advance in cancer treatment by successfully using Seraph® 100 blood filtration media to remove Circulating Tumor Cells (CTCs) from patients with advanced pancreatic cancer. This…
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF), a Canadian commercial dermatology company focused on growth and innovation, has announced the signing of an exclusive Manufacturing and Supply Agreement…
Lynch Regenerative Medicine, LLC (LRM) has successfully concluded its Series A financing to advance innovative skin rejuvenation and regeneration solutions based on FDA-approved pure platelet-derived growth factor (PDGF). Champion VC,…
MedImpact Healthcare Systems, Inc., the nation’s largest independent provider of health solutions, technology, and pharmacy benefit management services, has announced the successful completion of the integration of Elixir Solutions. This…
Sensorion (FR0012596468 – ALSEN), a pioneering biotechnology company specializing in hearing loss disorders, has unveiled new positive findings from its SENS-401 Phase 2a clinical trial. The data, focusing on the…
Teladoc Health (NYSE: TDOC), a global leader in comprehensive virtual care, is providing complimentary 24/7 general medical telehealth consultations to Texas residents, first responders, and others directly impacted by Hurricane…
Baxter International Inc. (NYSE), a global medtech leader, has published its 2023 Corporate Responsibility Report, highlighting its ongoing commitment to impactful global healthcare and transparent reporting on environmental, social, and…
EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, has completed its review of EO Care’s proprietary cost…
Zura Bio Limited (NASDAQ: ZURA), a clinical-stage immunology company specializing in novel dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and…
Galderma has announced the U.S. exclusive launch of two new innovations in its Cetaphil product line: the Vitamin C Serum and the Ceramide Serum. According to clinical studies, the Cetaphil…
Chemed Corporation (NYSE: CHE) announced today that it will release its financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, after the close of…